Active Ingredient(s): Acetaminophen + Caffeine + Dihydrocodeine Bitartrate
FDA Approved: * November 26, 2014
Pharm Company: * WRASER PHARMS LLC
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trezix Overview

Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) (as in co-dydramol) or aspirin. It was developed in Germany in 1908 and first marketed in 1911.[3] Commonly available as tablets, solutions, elixirs, and other oral forms, dihydrocodeine is also available in some countries as an injectable solution for deep subcutaneous and intra-muscular administration. As...

Read more Trezix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Trezix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Acetaminophen + Caffeine + Dihydrocodeine Bitartrate
  • Capsule: 320.5mg + 30mg + 16mg, 356mg + 30mg + 16mg
  • Tablet: 712.8mg + 60mg + 32mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Trezix: (4 results)

Sorted by National Drug Code
  • 63187-705 Trezix Oral Capsule by Proficient Rx Lp
  • 63629-5637 Trezix Oral Capsule by Bryant Ranch Prepack
  • 66992-340 Trezix Reformulated Oct 2011 (Apap 320.5 mg / Caffeine 30 mg / Dihydrocodeine Bitartrate 16 mg) Oral Capsule by Wraser LLC
  • 66992-840 Trezix Oral Capsule by Wraser LLC

Drugs with one or more similar ingredients: (300 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 30 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA